Xiao-Bin Zhang1, Xing-Tang Jiang, Qi-Chang Lin, Xiao Chen, Hui-Qing Zeng. 1. Department of Respiratory Medicine, Zhongshan Hospital, Xiamen University, No. 201, Hubin Nan Road, Siming District, Xiamen, 361004, Fujian, People's Republic of China, zhangxiaobincn@126.com.
Abstract
PURPOSE: The purpose of the present study was to evaluate the influence of continuous positive airway pressure (CPAP) on serum cystatin C, a novel biomarker of early renal impairment, among obstructive sleep apnea (OSA) patients. MATERIALS AND METHODS: Newly diagnosed severe OSA patients who treated with CPAP for 3 months were enrolled from two sleep laboratories. Serum biomarkers of renal impairment, cystatin C, creatinine and estimated glomerular filtration rate (eGFR), were detected before and after CPAP treatment. RESULTS: A total of 39 severe OSA patients were enrolled, 29 (74.4 %) were male, and mean age was 51.2 ± 12.2 years. After CPAP treatment, there were no changes of creatinine and eGFR (77.80 ± 20.00 vs. 75.3 ± 16.60 and 98.69 ± 31.74 vs. 100.20 ± 28.30, all p > 0.05), but cystatin C declined significantly (0.87 ± 0.18 vs. 0.77 ± 0.21, p = 0.000). CONCLUSION: CPAP can decrease cystatin C levels among severe OSA patients and may prevent the latent renal impairment.
PURPOSE: The purpose of the present study was to evaluate the influence of continuous positive airway pressure (CPAP) on serum cystatin C, a novel biomarker of early renal impairment, among obstructive sleep apnea (OSA) patients. MATERIALS AND METHODS: Newly diagnosed severe OSA patients who treated with CPAP for 3 months were enrolled from two sleep laboratories. Serum biomarkers of renal impairment, cystatin C, creatinine and estimated glomerular filtration rate (eGFR), were detected before and after CPAP treatment. RESULTS: A total of 39 severe OSA patients were enrolled, 29 (74.4 %) were male, and mean age was 51.2 ± 12.2 years. After CPAP treatment, there were no changes of creatinine and eGFR (77.80 ± 20.00 vs. 75.3 ± 16.60 and 98.69 ± 31.74 vs. 100.20 ± 28.30, all p > 0.05), but cystatin C declined significantly (0.87 ± 0.18 vs. 0.77 ± 0.21, p = 0.000). CONCLUSION: CPAP can decrease cystatin C levels among severe OSA patients and may prevent the latent renal impairment.
Authors: Katalin Fornadi; Anett Lindner; Maria E Czira; Andras Szentkiralyi; Alpar S Lazar; Rezso Zoller; Csilla Z Turanyi; Orsolya Veber; Marta Novak; Istvan Mucsi; Miklos Z Molnar Journal: Int Urol Nephrol Date: 2011-12-06 Impact factor: 2.370
Authors: David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly Journal: Chest Date: 2012-01-05 Impact factor: 9.410
Authors: Sofia B Ahmed; Paul E Ronksley; Brenda R Hemmelgarn; Willis H Tsai; Braden J Manns; Marcello Tonelli; Scott W Klarenbach; Rick Chin; Fiona M Clement; Patrick J Hanly Journal: PLoS One Date: 2011-04-29 Impact factor: 3.240